ATE261960T1 - Sulfonamide mit elastase inhibierender wirkung - Google Patents

Sulfonamide mit elastase inhibierender wirkung

Info

Publication number: ATE261960T1
Authority: AT; Austria
Prior art keywords: chem; alkyl; alkoxy; taken together; represent
Prior art date: 1995-09-27

Application number

AT96307048T

Other languages

English (en)

Inventor

Takahiko Nakae

Masashi Kato

Takehito Fujita

Kazuhito Kawabata

Hiroyuki Ohno

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-27

Filing date

1996-09-27

Publication date

2004-04-15

1995-09-27 Priority claimed from JP7272058A external-priority patent/JPH09165365A/ja

1996-09-27 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2004-04-15 Application granted granted Critical

2004-04-15 Publication of ATE261960T1 publication Critical patent/ATE261960T1/de

Links

102000016387 Pancreatic elastase Human genes 0.000 title abstract 2
108010067372 Pancreatic elastase Proteins 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title abstract 2
229940124530 sulfonamide Drugs 0.000 title abstract 2
150000003456 sulfonamides Chemical class 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
125000004953 trihalomethyl group Chemical group 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
229930194542 Keto Natural products 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000001118 alkylidene group Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
150000001721 carbon Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
-1 cyano, amidino Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000000468 ketone group Chemical group 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/64—X and Y being nitrogen atoms, e.g. N-sulfonylguanidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C07D203/24—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Surgical Instruments (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)

AT96307048T 1995-09-27 1996-09-27 Sulfonamide mit elastase inhibierender wirkung ATE261960T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP7272058A JPH09165365A (ja)	1995-09-27	1995-09-27	スルホンアミド誘導体
JP4566396		1996-02-08

Publications (1)

Publication Number	Publication Date
ATE261960T1 true ATE261960T1 (de)	2004-04-15

Family

ID=26385695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96307048T ATE261960T1 (de)	1995-09-27	1996-09-27	Sulfonamide mit elastase inhibierender wirkung

Country Status (10)

Country	Link
US (2)	US5795890A (de)
EP (1)	EP0769498B9 (de)
KR (1)	KR100266467B1 (de)
AT (1)	ATE261960T1 (de)
AU (1)	AU714025B2 (de)
CA (1)	CA2186665A1 (de)
DE (1)	DE69631865D1 (de)
HU (1)	HUP9602635A3 (de)
MX (1)	MX9604398A (de)
NO (1)	NO307251B1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR980009238A (ko)	1995-07-28	1998-04-30	우에노 도시오	설포닐아미노산 유도체
US6872742B2 (en)	1996-08-28	2005-03-29	The Procter & Gamble Company	Substituted cyclic amine metalloprotease inhibitors
CZ63199A3 (cs)	1996-08-28	1999-08-11	The Procter & Gamble Company	Sloučeniny typu substituovaných cyklických aminů jako inhibitory metaloproteáz, způsob jejich přípravy a použití jako léčiv
DE19742263A1 (de) *	1997-09-25	1999-04-01	Asta Medica Ag	Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva
CN1306525A (zh) *	1998-06-03	2001-08-01	Gpinil控股公司	含有多个杂原子的杂环化合物的羧酸或其电子等排物
WO1999062880A1 (en)	1998-06-03	1999-12-09	Gpi Nil Holdings, Inc.	N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
US6251932B1 (en)	1998-09-25	2001-06-26	Asta Medica Ag	Immunophilin ligands
CN1349498A (zh) *	1999-03-03	2002-05-15	宝洁公司	含有链烯基和炔基的金属蛋白酶抑制剂
AU7052300A (en)	1999-08-27	2001-03-26	Eli Lilly And Company	Hypoglycemic n,n-arylsulfonylglycine compounds
TW200303742A (en) *	2001-11-21	2003-09-16	Novartis Ag	Organic compounds
DE10229777A1 (de) *	2002-07-03	2004-01-29	Bayer Ag	Indolin-Phenylsulfonamid-Derivate
DE10300015A1 (de) *	2003-01-03	2004-07-15	Aventis Pharma Deutschland Gmbh	Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen
DE10335449A1 (de) *	2003-08-02	2005-02-17	Bayer Healthcare Ag	Bicyclische Indolinsulfonamid-Derivate
US7622491B2 (en) *	2004-08-13	2009-11-24	Metabolex Inc.	Modulators of PPAR and methods of their preparation
EP1916985A4 (de) *	2005-08-19	2010-06-09	Elan Pharm Inc	Verbrückte n-cyclische sulfonamid-hemmer der gammasekretase
GB0526257D0 (en) *	2005-12-22	2006-02-01	Novartis Ag	Organic compounds
AR059518A1 (es) *	2006-02-17	2008-04-09	Wyeth Corp	Metodos para preparar alcoholes sustituidos con sulfonamidas y sus compuestos intermedios
EP1984347A1 (de) *	2006-02-17	2008-10-29	Wyeth a Corporation of the State of Delaware	Selektive n-sulfonylierung von 2-amino-trifluoroalkyl-substituierten alkoholen
CN101535304A (zh)	2006-09-21	2009-09-16	埃迪威克斯生物科学公司	丝氨酸水解酶抑制剂
EP3932914A1 (de)	2015-03-13	2022-01-05	Valo Health, Inc.	Alpha-cinnamid-verbindungen und zusammensetzungen als hdac8-inhibitoren
GB202108544D0 (en) *	2021-06-15	2021-07-28	Z Factor Ltd	Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CN116411028B (zh) *	2023-01-06	2024-08-16	西南大学	桔小实蝇嗅觉受体OR43a-1和OR63a-2的应用及其突变体的构建方法
CN119638624A (zh) *	2023-09-15	2025-03-18	上海壹迪生物技术有限公司	中性粒细胞弹性蛋白酶抑制剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0222608B1 (de) *	1985-11-12	1991-09-11	Ono Pharmaceutical Co., Ltd.	p-Guanidinbenzoesäurederivate und pharmazeutische Mittel, die sie als aktiven Inhaltsstoff enthalten
US5017610A (en) *	1988-06-13	1991-05-21	Ono Pharmaceutical Co., Ltd.	Derivatives of p-substituted phenyl ester of pivalic acid
US5214191A (en) *	1990-05-22	1993-05-25	Cortech, Inc.	Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
AU647838B2 (en) *	1990-11-07	1994-03-31	Cortech, Inc.	Ester inhibitors
US5240956A (en) *	1990-11-07	1993-08-31	Cortech, Inc.	Ester inhibitors
EP0539223A1 (de) *	1991-10-25	1993-04-28	Ono Pharmaceutical Co., Ltd.	Tetrahydrat des Mononatriumsalzes eines Glycerinderivates, welches einen Elastase inhibierenden Effekt hat
US5216022A (en) *	1991-12-19	1993-06-01	Cortech, Inc.	Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase

1996
- 1996-09-24 US US08/718,722 patent/US5795890A/en not_active Expired - Fee Related
- 1996-09-24 KR KR1019960041963A patent/KR100266467B1/ko not_active Expired - Fee Related
- 1996-09-25 AU AU65837/96A patent/AU714025B2/en not_active Ceased
- 1996-09-26 NO NO964045A patent/NO307251B1/no not_active IP Right Cessation
- 1996-09-26 HU HU9602635A patent/HUP9602635A3/hu unknown
- 1996-09-27 AT AT96307048T patent/ATE261960T1/de not_active IP Right Cessation
- 1996-09-27 CA CA002186665A patent/CA2186665A1/en not_active Abandoned
- 1996-09-27 DE DE69631865T patent/DE69631865D1/de not_active Expired - Lifetime
- 1996-09-27 EP EP96307048A patent/EP0769498B9/de not_active Expired - Lifetime
- 1996-09-27 MX MX9604398A patent/MX9604398A/es unknown
1998
- 1998-02-26 US US09/031,192 patent/US5998410A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0769498B1 (de)	2004-03-17
HUP9602635A3 (en)	1998-12-28
KR100266467B1 (ko)	2000-10-02
HUP9602635A2 (en)	1997-11-28
MX9604398A (es)	1997-09-30
NO307251B1 (no)	2000-03-06
US5795890A (en)	1998-08-18
AU714025B2 (en)	1999-12-16
EP0769498B9 (de)	2004-11-10
CA2186665A1 (en)	1997-03-28
DE69631865D1 (de)	2004-04-22
NO964045L (no)	1997-04-01
US5998410A (en)	1999-12-07
NO964045D0 (no)	1996-09-26
AU6583796A (en)	1997-04-10
EP0769498A1 (de)	1997-04-23
HU9602635D0 (en)	1996-11-28
KR970015569A (ko)	1997-04-28

Legal Events

Date	Code	Title	Description
2004-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69631865D1 (de)	2004-04-22	Sulfonamide mit Elastase inhibierender Wirkung
DE69418704D1 (de)	1999-07-01	Anthranilsäure derivate
DK1104760T3 (da)	2003-06-30	Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
EA200300531A1 (ru)	2003-10-30	Производные фталазинона
DE69331843D1 (de)	2002-05-29	Xanthine-Derivate als Antidepressiva
DK0889876T3 (da)	2001-09-24	Meta-substituerede phenylensulfonamidderivater
HRPK20040271B3 (en)	2006-02-28	Indole derivatives as cox ii inhibitors
AU629048B2 (en)	1992-09-24	N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their use
ATE268330T1 (de)	2004-06-15	Azaidole mit serotonin rezeptor affinität
DK0641770T3 (da)	1998-06-02	Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ES2046195T3 (es)	1994-02-01	Un procedimiento para la preparacion de los derivados de prolinal.
ATE231487T1 (de)	2003-02-15	2-phenoxyanilin-derivate
ATE133672T1 (de)	1996-02-15	Thienopyridin-derivate, deren herstellung und verwendung
ES2076959T3 (es)	1995-11-16	Nuevos derivados de amino acidos.
ES2118343T3 (es)	1998-09-16	Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO921282D0 (no)	1992-04-02	Benzotiazolderivater og deres anvendelse
DE69624459D1 (de)	2002-11-28	Kondensierte indan-derivate und ihre salze
DK369289D0 (da)	1989-07-26	Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
DE3781769D1 (de)	1992-10-22	1-carbamoyl-2-pyrazolin-derivate mit herbizidischer wirkung.
TH17540A (th)	1996-01-23	อนุพันธ์ของเบนซีนซัลโฟแนมีด และกรรมวิธีเตรียมสาร?เหล่านั้น
GR3033499T3 (en)	2000-09-29	Composition for remedying drug dependence